Wockhardt Limited (BOM:532300)
India · Delayed Price · Currency is INR 1,885.80
+55.65 (3.04%)
At close: Aug 21, 2026
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 306.51 billion as of August 21, 2026. Its market cap has increased by 26.89% in one year.
Market Cap
306.51B
Enterprise Value
326.11B
Revenue
36.53B
Ranking
n/a
PE Ratio
74.94
Stock Price
1,885.80
ChartMarket Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 306.51B, an increase of 1,661.16%. That is a compound annual growth rate of 11.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 306.51B | 30.43% |
| Dec 31, 2025 | 235.00B | 2.08% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 560.98B |
| GlaxoSmithKline Pharmaceuticals | 513.99B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 297.76B |
| Granules India | 207.68B |
| Caplin Point Laboratories | 195.43B |
| AstraZeneca Pharma India | 187.71B |
| Jubilant Pharmova | 137.58B |